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Background/aim: Leptin, ghrelin, and glucagon-like peptide-1 (GLP-1) affect hunger, satiety feelings, and food intake. We hypothesized
that during Ramadan, if the brain knows that the body will be hungry until sunset, there may be differences between leptin, ghrelin, and
GLP-1 levels in Ramadan and non-Ramadan fasting.
Materials and methods: This study had two phases. In the first phase, the participants were asked to skip the dawn meal of Ramadan
(suhur), so that 12 h of fasting could be achieved. Participants ceased food intake at midnight, and at noon blood was drawn. Eight
participants were selected as a subgroup. These participants gave blood three times a day to detect hormonal changes during Ramadan.
Six months later, in the second phase, blood samples were obtained at noon from participants after 12 h of fasting.
Results: Analysis was conducted on 30 patients [19 males (63.3%) and 11 females (36.7%)]. There was a significant difference in leptin,
ghrelin, and GLP-1 levels between Ramadan fasting and non-Ramadan fasting (P = 0.04, P = 0.02, and P < 0.001, respectively). In the
subgroup analysis, there was no statistically significant difference in leptin, ghrelin, and GLP-1 levels over time.
Conclusion: The results of this study suggest that the nervous and gastrointestinal systems may behave differently in religious fasting
than in nonreligious fasting.
Key words: Leptin, ghrelin, glucagon-like peptide-1, fasting

1. Introduction
It is a known fact that there is a link between the central
nervous system and the gastrointestinal system. In recent
years, this link has been further elucidated, especially with
the discovery of new molecules affecting both brain and
gut.
One of these molecules is leptin, also known as the
‘satiety’ hormone. It is produced mostly by adipose tissue
(1) and inhibits hunger in the hypothalamus (2). Another
molecule interacting with appetite is ghrelin. Ghrelin
is produced in the gastrointestinal tract, and its main
purpose is to stimulate hunger in the brain (3). It acts on the
hypothalamus and increases hunger and gastric secretions
(4). Glucagon-like peptide-1 (GLP-1) is a gut peptide, an
incretin that is produced mainly from intestinal L cells in
the gastrointestinal system (5) and from the solitary tract
nucleus of the brain (6). In modern practice, although
its analogs are used for treatment of type 2 diabetes, its
functions include lessening the motivational effects of
* Correspondence: wattersonx@gmail.com
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eating and decreasing the quantity and frequency of food
consumption, leading to an early ‘fullness’ feeling (7).
Ramadan is a unique month in the Islamic calendar.
During Ramadan, Muslims fast from sunrise to sunset.
When they wake up, they know that they will be hungry
for the rest of the day. We hypothesized that if the brain
knows that the body will be hungry until sunset, the
aforementioned appetite-related hormone levels may be
different than in normal fasting. In this regard, we aimed
to identify the differences between leptin, ghrelin, and
GLP-1 levels in Ramadan and non-Ramadan fasting.
2. Materials and methods
2.1. Study design
Ethics committee approval for this study was obtained
from the relevant ethics board (Decision No. 2013/0024).
The study consisted of two phases: the first phase was in
the month of Ramadan in 2013 (July) and the second
phase was 6 months later (January 2014). In the first phase,
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healthy volunteers were recruited by hospital staff and
blood samples were collected in the last week of Ramadan.
In the second phase, blood samples were obtained 6
months later from the same participants.
2.2. Participants
Power analysis was conducted to determine the sample
size needed. Thirty participants were recruited according
to the power analysis, and five more were included in
the study to compensate for possible drop-outs. The
study protocol was explained to each screened candidate.
Inclusion criteria of the participants consisted of being
≥18 years old, fasting for the whole month, and giving
consent. Exclusion criteria consisted of having a medical
disorder or using any medical agent, pregnancy, and not
fasting for the whole month. To adjust the neurological
and gastroenterological system to fasting, we recruited
patients who fasted the whole month and we collected the
blood samples in the last week of Ramadan.
2.3. Protocol
2.3.1. First phase
Participants were asked to skip the dawn meal of Ramadan
(suhur) so that 12 h of fasting could be achieved. They
ceased food intake at midnight and blood was drawn at
noon. Eight participants were selected as a subgroup. We
collected blood samples from the subgroup patients three
times (0900, 1200, and 1700 hours) to detect hormonal
changes during the day in Ramadan. The remaining
participants gave blood only at noon (1200 hours).
2.3.2. Second phase
To ensure that participants were free of the influence of
Ramadan, the study protocol was repeated 6 months later. If
the participant had a different BMI or waist circumference
value from the first phase’s results, they were excluded
from the analysis. Participants were asked to cease food
intake again at midnight, and after 12 h of fasting, blood
samples were obtained at noon. No subgroup was formed
in the second phase.
2.4. Biochemical measurements
2.4.1. Blood samples
Venous blood samples were collected into two different
blood tubes: a plain blood tube to obtain a serum sample
for measuring glucose, insulin, and leptin, and a prechilled
BD P800 blood collection tube (Becton, Dickinson
and Company, NJ, USA), which contained spray-dried
K2EDTA anticoagulant and proprietary additives to collect
and preserve plasma for measuring metabolic markers,
including GLP-1 and ghrelin. After the collection of blood,
serum and plasma samples were immediately separated
by cold centrifugation and stored at –80 °C until further
analysis.

2.4.2. Analytical methods
All the samples were measured together centrally to
prevent interassay variation. Serum glucose was measured
by hexokinase method, using an Architect c8000
biochemistry analyzer (Abbott Laboratories, Abbott
Park, IL, USA). Serum insulin levels were measured
using a chemiluminescent immunoassay method with a
UniCelDxI 800 immunoassay system (Beckman Coulter
Inc., Carlsbad, CA, USA). A commercial ELISA kit was
used for serum leptin determinations (Catalog No. EIA2395; DRG Instruments GmbH, Marburg, Germany). The
lowest limit of this assay was 1.0 ng/mL. The intraassay
coefficients of variation (CVs) at 3.15 and 24.62 ng/mL for
leptin were 5.95% and 6.91%, respectively. The interassay
CVs of the test were 11.55% and 6.66 % at 2.71 and 26.15
ng/mL, respectively.
Plasma total ghrelin was measured with a total ghrelin
(both intact and des-octanoyl forms) ELISA kit (Catalog
No. EZGRT-89K; Millipore, Watford, UK). The analytical
sensitivity of the test was 50 pg/mL. The intraassay CVs
at 384.6, 904.5, and 1522.4 pg/mL for ghrelin were 1.26%,
0.9%, and 0.99%, respectively. The interassay CVs of
the test were 7.81%, 6.28%, and 6.18% at the previous
concentrations, respectively. Plasma GLP-1 levels were
measured by a GLP-1 active ELISA kit (Catalog No. EGLP35K; Millipore), in which active GLP-1 (7-36 amide) can
be measured without cross-reacting with the inactive
forms of GLP-1. The lowest level that could be detected
by the assay was 2 pM. The intraassay CVs at 4, 8, 12, 28,
and 76 pM for active GLP-1 were 8%, 7%, 6%, 7%, and
9%, respectively. The interassay CVs of the test were 13%,
12%, 7%, 7%, and <1% at the previous concentrations,
respectively.
Manufacturers’ protocols were followed for all
commercial kits. Insulin resistance was assessed based on
the fasting insulin and plasma glucose values, using the
homeostasis model assessment (HOMA)-IR model.
2.5. Statistical analysis
Statistical analyses were conducted with SPSS 21.0 (IBM
Corp., Armonk, NY, USA). The normality of distribution
of variables was assessed with the Shapiro–Wilk and
Kolmogorov–Smirnov tests. Subjects were compared for
differences in two measurements using the paired samples
t-test or the Wilcoxon test. The correlations between
variables were determined by Pearson correlation test or
Spearman’s rho. Bonferroni correction was used when
necessary. Data were expressed as means ± SD. P < 0.05
(two-tailed) was considered statistically significant. For
subgroup analysis, we first executed a Friedman test and
then used Bonferroni correction. Wilcoxon signed-rank
tests were used to assess the parameters that showed
significant differences with time.
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3. Results
A total of 35 participants were recruited. Three were lost
in follow-up, one became pregnant during the second
phase, and one had different BMI and waist circumference
values from the first phase. Analysis was conducted on the
remaining 30 patients [19 males (63.3%) and 11 females
(36.7%)]. The demographic characteristics of the patients
are shown in the Table.
There was no significant difference in glucose levels
between Ramadan and non-Ramadan fasting, whereas the
mean insulin level was significantly higher in the Ramadan
group (P = 0.001).
Mean leptin levels were 7.1 ± 6 ng/mL in Ramadan
fasting and 5.8 ± 4 ng/mL in non-Ramadan fasting (P =
0.04). Ghrelin levels were higher in non-Ramadan fasting
compared to Ramadan fasting, i.e. 589 ± 335 pg/mL vs.
535 ± 355 pg/mL (P = 0.02). Mean GLP-1 levels were 5.6 ±
1 pg/mL in Ramadan fasting and 4.6 ± 0.7 pg/mL in nonRamadan fasting (P < 0.001) (Figures 1A–1C).
Although there was a correlation between BMI and
ghrelin, GLP-1, and leptin levels in Ramadan fasting (P =
0.009, r = –0.45; P = 0.006, r = –0.52; and P = 0.001, r =
0.44, respectively), a correlation with BMI was observed
only with ghrelin levels in non-Ramadan fasting (P =
0.009, r = –0.55). The only significant correlation with
waist circumference was observed with leptin levels only
in Ramadan fasting (P = 0.03, r = 0.57).
In the subgroup analysis, there was no statistically
significant difference in leptin, ghrelin, and GLP-1 levels
over time (0900, 1200, and 1700 hours); however, there
was significant difference in glucose levels (P = 0.01 for
1200 and 1700 hours, and P = 0.01 for 0900 and 1700
hours).
4. Discussion
The results of this study indicate that there is difference
in metabolic parameters between religious fasting and
nonreligious fasting. To the best of our knowledge, this is
the first study to show the differences of ghrelin and GLP-1
levels in religious fasting.

This difference can be attributed to neurohumoral
mechanisms. In Ramadan fasting, one wakes without the
intention to eat; however, in non-Ramadan fasting, one
intends to eat after the prohibition is lifted (for health
purposes, after 8 h of fasting when blood is drawn, etc.).
This intention to eat or not to eat may be the reason for the
difference we observed.
In our study, leptin levels were high during Ramadan
fasting and lower in non-Ramadan fasting, indicating that
the brain had adjusted itself to satiety during Ramadan.
Similarly, GLP-1 levels were higher in Ramadan fasting,
whereas ‘hunger’ hormone ghrelin levels were lower
compared to non-Ramadan fasting, thus supporting our
hypothesis.
There are other studies that have tested this hypothesis.
In a report by Alzoghaibi et al., ghrelin levels did not
show any significant difference between months prior to
Ramadan and Ramadan (8). Furthermore, although leptin
levels were reduced, there was no significant difference
between Ramadan and non-Ramadan months. Their study
had a relatively smaller cohort than our study with eight
participants, and their methodology differed regarding the
timeline.
In another study by Ajabnoor et al., there was a statistical
difference between leptin levels prior to Ramadan with 10
h of fasting and during Ramadan with 6–7 h of fasting
(9). The number of participants in this study was similar
to our study. In this study, the mean leptin levels of the
participants in Ramadan fasting was more than twice as
high as our cohort’s results. This discrepancy is probably
due to methodological differences. In our study, because
the participants had skipped suhur, 12-h fasting was
possible. However, in Ajabnoor et al.’s study, the patients
stopped eating at 0430 hours and samples were drawn
at 0900 hours. Therefore, the subjects in Ajabnoor et al.’s
study were not as hungry as our participants.
In a report by Hadi et al., there was no difference in
leptin levels before, during, and after Ramadan fasting

Table. Demographic characteristics of the participants.
Variables

Mean (SD)

Age, years

36.1 ± 8

Body mass index (kg/cm2)

26 ± 3.8

Waist circumference (cm)
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Males

Females

91.5 ± 9

81.7 ± 11

Weight (kg)

75 ± 13

Height (cm)

170 ± 9
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Panel A: Leptin levels in Ramadan and in normal fasting

Panel B: Ghrelin levels in Ramadan and in normal fasting
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Figure 1. Differences in leptin (A), ghrelin (B), and glucagon-like peptide (C) levels.

(10). In this study, 56 patients with stable cardiac disease
were recruited. Approximately 70% of the patients
recruited in this study had a BMI of ≥25; in our study, this
rate was 60%. Leptin resistance in these patients may have
caused higher leptin levels for the participants of this study
compared to our results (12.7 ng/mL vs. 7.1 ng/mL).
Another study by Mesci et al. tested this hypothesis
with ghrelin, leptin, and adiponectin levels. Although
they observed lower leptin and higher ghrelin levels in
nonreligious fasting, their results were not statistically
significant (11).
Another interesting result of this study was the findings
in our subgroup. In our subgroup analysis, there was no
decrease or increase in leptin, ghrelin, and GLP-1 levels

during the day in Ramadan fasting, although glucose
significantly decreased. This supports the fact that in
intentional fasting due to religious beliefs, the brain is set
up to be hungry for the rest of the day. Consequently, no
metabolic change is detected.
There are several limitations to this study. First, our
subgroup was relatively small with eight participants.
Second, the Ramadan month of the study was in July
according to the Gregorian calendar and hence fasting
time was almost 17 h. To investigate any possible effect
of daytime duration on fasting and hormones, the same
protocol should be applied to a Ramadan month in winter.
Finally, blood samples were drawn during the last week of
Ramadan. For comparison, another set of blood samplings
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could have been drawn during the first week. Any possible
differences between the results of these weeks would
strengthen the study.
In conclusion, we found significant differences in
leptin, ghrelin, and GLP-1 levels between Ramadan fasting

and non-Ramadan fasting. We also noted that these
molecular parameters do not change during the fast. These
results constitute progress towards elucidating how the
brain adapts to hunger.
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